The Role of Endothelial Progenitor Cell in Cardiovascular Disease Risk Factors

Rahmawati Minhajat1, Dina Nilasari, Syakib Bakri

  • 1Department of Internal Medicine. Faculty of Medicine Hasanuddin University, Makassar, Indonesia.

Insights

Endothelial progenitor cells (EPCs), circulating in blood, have stem-like properties crucial for vascular repair. Higher EPC levels indicate better cardiovascular health and potential for treating endothelial dysfunction.

Area of Science:

  • Vascular Biology
  • Stem Cell Research
  • Regenerative Medicine

Background:

  • Endothelial progenitor cells (EPCs) originate from bone marrow and circulate in peripheral blood.
  • EPCs exhibit stem cell-like characteristics but possess limited proliferative and differentiation capacities.
  • Their discovery has significantly impacted vascular biology, offering new therapeutic avenues.

Purpose of the Study:

  • To highlight the role of EPCs in vascular integrity and repair.
  • To emphasize the clinical implications of EPCs in treating endothelial dysfunction.
  • To establish the link between circulating EPC levels and cardiovascular health.

Main Methods:

  • Characterization of EPCs from bone marrow and peripheral blood.
  • Assessment of EPC proliferation and differentiation potential.
  • Correlation analysis of EPC levels with reendothelialization and neovascularization markers.

Main Results:

  • EPCs play a key role in vasculogenesis and maintaining vascular integrity.
  • Increased circulating EPCs correlate positively with reendothelialization and neovascularization.
  • EPCs are closely associated with overall cardiovascular health.

Conclusions:

  • EPCs are vital for vascular repair and integrity.
  • Circulating EPC levels serve as an important indicator of cardiovascular health.
  • EPCs hold significant therapeutic potential for endothelial dysfunction diseases.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
943
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.6K